ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness

Chen, Xiangyu; Lin, Yao; Yue, Shuai; Yang, Yang; Yang, Xiaofan; He, Junjian; Gao, Leiqiong; Li, Zhirong; Hu, Li; Tang, Jianfang; Wang, Yifei; Tian, Qin; Hao, Yaxing; Xu, Lifan; Huang, Qizhao; Cao, Yingjiao*; Ye, Lilin*南方医科大学
Vaccine2023-7-31DOI: 10.1016/j.vaccine.2023.06.053
6阅读
引用收藏
分享

摘要

The COVID-19 vaccinations are crucial in protecting against the global pandemic. However, accumulating studies revealed the severely blunted COVID-19 vaccine effectiveness in cancer patients. The PD-1/PD-L1 immune checkpoint blockade (ICB) therapy leads to durable therapeutic responses in a subset of cancer patients and has been approved to treat a wide spectrum of cancers in the clinic. In this regard, it is piv-otal to explore the potential impact of PD-1/PD-L1 ICB therapy on COVID-19 vaccine effectiveness during ongoing malignancy. In this study, using preclinical models, we found that the tumor-suppressed COVID-19 vaccine responses are largely reverted in the setting of PD-1/PD-L1 ICB therapy. We also identified that the PD-1/PD-L1 blockade-directed restoration of COVID-19 vaccine effectiveness is irrelevant to anti-tumor therapeutic outcomes. Mechanistically, the restored COVID-19 vaccine effectiveness is entwined with the PD-1/PD-L1 blockade-driven preponderance of follicular helper T cell and germinal center responses during ongoing malignancy. Thus, our findings indicate that PD-1/PD-L1 blockade will greatly normalize the responses of cancer patients to COVID-19 vaccination, while regardless of its anti-tumor efficacies on these patients. & COPY; 2023 Elsevier Ltd.

学科与关键词

关键词
COVID-19 vaccineSARS-CoV-2 RBDT FH cellPD-1PD-L1 blockadeCancer immunotherapy
相关
加载中…
  • Impaired serological response to COVID-19 vaccination following anticancer therapy: A systematic review and meta-analysis
    Tang, Kefu*; Wei, Zhiying; Wu, Xi*Journal of Medical Virology, 2022, 94(10): 4860-4868.被引 10
  • Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors
    Qin, Tianyu; Guo, Ensong; Lu, Funian; Fu, Yu; Liu, Si; Xiao, Rourou; Wu, Xue; Liu, Chen; He, Chao; Wang, Zizhuo; Qin, Xu; Hu, Dianxing; You, Lixin; Li, Fuxia; Li, Xi; Huang, Xiaoyuan; Ma, Ding; Xu, Xiaoyan; Yang, Bin*; Fan, Junpeng*Aging-US, 2021, 13(23): 24943-24962.被引 2
  • The primordial differentiation of tumor-specific memory CD8+T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
    Huang, Qizhao; Wu, Xia; Wang, Zhiming; Chen, Xiangyu; Wang, Lisha; Lu, Yijun; Xiong, Dan; Liu, Qiao; Tian, Yuhan; Lin, Huayu; Guo, Junyi; Wen, Shuqiong; Dong, Wei; Yang, Xiaofan; Yuan, Yuchen; Yue, Zhengliang; Lei, Shun; Wu, Qing; Ran, Ling; Xie, Luoyingzi; Wang, Yifei; Gao, Leiqiong; Tian, Qin; Zhou, Xinyuan; Sun, Beicheng*; Xu, Lifan*; Tang, Zhonghui*; Ye, Lilin*Cell, 2022, 185(22): 4049-+.被引 61
查看全部 →

发表信息

论文状态
公开发表
期刊
Vaccine
发表日期
2023-07-31
卷期
第 41 卷, 第 34 期
页码
4986-4995
DOI
10.1016/j.vaccine.2023.06.053
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31900642]; National Natural Science Fund for Distinguished Young Scholars [31825011]; National Science and Technology Major Project [2017ZX10202102-006-002]

作者

  • C

    Chen, Xiangyu (第一作者)

    southern med univ

  • L

    Lin, Yao

    third mil med univ

查看全部 17 位作者收起作者
  • Y

    Yue, Shuai

    third mil med univ

  • Y

    Yang, Yang

    southern med univ

  • Y

    Yang, Xiaofan

    southern med univ

  • H

    He, Junjian

    third mil med univ

  • G

    Gao, Leiqiong

    third mil med univ

  • L

    Li, Zhirong

    third mil med univ

  • H

    Hu, Li

    third mil med univ

  • T

    Tang, Jianfang

    third mil med univ

  • W

    Wang, Yifei

    southern med univ

  • T

    Tian, Qin

    southern med univ

  • H

    Hao, Yaxing

    third mil med univ

  • X

    Xu, Lifan

    third mil med univ

  • H

    Huang, Qizhao

    southern med univ

  • C

    Cao, Yingjiao (通讯)

    southern med univ

  • Y

    Ye, Lilin (通讯)

    third mil med univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417